NCT04023266View on ClinicalTrials.gov

A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

November 15, 2020

Study Completion Date

January 1, 2022

Conditions
STEMI
Interventions
DRUG

Intravenous N-Acetylcysteine

Intravenous N-acetyl cysteine bolus and infusion as described in the experimental arm.

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04023266 - A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI | Biotech Hunter | Biotech Hunter